BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
Loading...
Loading...

Novartis Found Symp. 2008 289 4-16 Pages on BioPortfolio:

BioPortfolio - Novartis Found Symp. 2008 289 4-16
10th July, 2008, Department of Psychiatry, University of North Carolina at Chapel ... Terms used to find this page: Novartis Found Symp. 2008 289 4-16 | . ...
http://www.bioportfolio.com/search/Novartis_Found_Symp._2008...

BioPortfolio - Schizophrenia Psychotic Features - InDepth
Program in Cognitive Neuroscience and Schizophrenia, Nathan Kline- Novartis Found Symp. 2008;289:4-16; discussion 17-22, 87-93. ...
http://www.bioportfolio.com/indepth/Schizophrenia_Psychotic_...

Results from other life science and pharmaceutical sites:

Phenomenology, aetiology and treatment of schizoph...[Novartis ...
1: Novartis Found Symp. 2008;289:4-16; discussion 17-22, 87-93.Links. Phenomenology, aetiology and treatment of schizophrenia. ...
http://www.ncbi.nlm.nih.gov/pubmed/18497092...

The Pathology of Influenza Virus Infections
Author manuscript; available in PMC 2008 August 11. ...... Novartis Found Symp. 2006;279:56–60. discussion 60–65, 216–19. [PubMed]. 31. Cent. Dis. Control. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=25...

Untitled
By experimentally infecting wild ducks, we found that tufted ...... syndrome (drug rash with eosinophilia and systemic symp- ...
http://www.cdc.gov/EID/content/14/4/pdfs/vol14no04.pdf...

The Pharmacology of Cyclic Nucleotide-Gated Channels: Emerging ...
Author manuscript; available in PMC 2008 July 16. ...... Novartis Found Symp. 2002;241:206–18. [PubMed]. 172. Nau C, Wang GK. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=24...

Studies l4,1999 546-6666 Min-U-Script@ (3)
222:15; 251:6; 252:3,8;. 253:15; 288:17,21; 289:3;. 296:4,16. consequence ...... Novartis 95:12; 116:24;. 150:22. novel 123:19; 167:4; ...
http://www.fda.gov/OHRMS/DOCKETS/AC/99/transcpt/3571t1d.pdf...

Annual Report
PI-Cravero, J P PHS-AHRQ G 30000 N Dartmouth Symposium on ...... PI-Ely, P NOVARTIS PHARM CORP C 105000 N A Phase III Study of ST1571 vs IFN-a ...
http://www.dartmouth.edu/~osp/docs/FY01_Rpt.pdf...

082608
289, ABIMO0141, Biogenesis and Molecular Pathogenesis of CFTR ...... in patients with metastatic Carcinoid Tumors, Novartis Pharmaceuticals Corporation ...
http://www.ohsu.edu/research/rda/spa/docs/crosswalk.xls...

Overexpenditure index
289, 133061, 2R53O, 253O0, 133167, Collaborative Research: A Proposal for the ...... 1539, 3R47Q, 347Q0, 09904O, Clinical Trial Phase 1b, Novartis Vaccines ...
http://www.unm.edu/~fiscal/docs/Overexpenditure%20index%20li...

Dept YTD
289, AS, 31795 AS-Environmental Sciences, 119274, AS-ENVS SWAS11 ...... 2812, MD, 41200 MD-RADL Rad Research, 122268, MD-RADL Kramer Novartis Lotrel ...
http://www.virginia.edu/finance/finanalysis/By%20Project%20R...

Novartis GB06 engl.
2007 and 2008 set to be exciting years for new product launches, with approvals ...... capital structure of Novartis AG over the last two years can be found ...
http://www.novartis.com/downloads/investors/reports/AR06_E_w...

Google Custom Search

Search
  

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo